<DOC>
	<DOCNO>NCT00209794</DOCNO>
	<brief_summary>To evaluate intermittent preventive treatment infant ( IPTi ) consist SP [ Fansidar ] give EPI scheme alongside routine immunisation 3 , 4 9 month age reduce de incidence clinical malaria 12 month age</brief_summary>
	<brief_title>IPTi Mozambican Infants Malaria Prevention</brief_title>
	<detailed_description>The study randomise , double blind , placebo-controlled trial antimalarial drug sulphadoxine-pyrimethamine administer intermittently 3 , 4 9 month age EPI scheme time routine immunisation . Children randomize placebo SP treatment group block randomization , expect similar age distribution similar number child group . Doses sulphadoxine ( 25 mg/kg ) -pyrimethamine ( 1.25 mg/kg ) ( SP ) placebo give health assistant accord bodyweight ( quarter tablet &lt; 5kg , half 5-10 kg , whole tablet child &gt; 10 kg ) . The tablet crash diluted water administration .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<criteria>Children study area Signed informed consent History drug allergy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Months</maximum_age>
	<verification_date>November 2006</verification_date>
</DOC>